ID   ISPF_ECOLI              Reviewed;         159 AA.
AC   P62617; P36663; Q2MA83;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 123.
DE   RecName: Full=2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase;
DE            Short=MECDP-synthase;
DE            Short=MECPP-synthase;
DE            Short=MECPS;
DE            EC=4.6.1.12;
GN   Name=ispF; Synonyms=mecS, ygbB; OrderedLocusNames=b2746, JW2716;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=MP180;
RX   PubMed=7928962; DOI=10.1128/jb.176.19.6015-6022.1994;
RA   Li C., Ichikawa J.K., Ravetto J.J., Kuo H.-C., Fu J.C., Clarke S.;
RT   "A new gene involved in stationary-phase survival located at 59
RT   minutes on the Escherichia coli chromosome.";
RL   J. Bacteriol. 176:6015-6022(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PARTIAL PROTEIN SEQUENCE, FUNCTION
RP   AS AN MECDP-SYNTHASE, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, AND
RP   COFACTOR.
RX   PubMed=10694574; DOI=10.1073/pnas.040554697;
RA   Herz S., Wungsintaweekul J., Schuhr C.A., Hecht S., Luettgen H.,
RA   Sagner S., Fellermeier M., Eisenreich W., Zenk M.H., Bacher A.,
RA   Rohdich F.;
RT   "Biosynthesis of terpenoids: YgbB protein converts 4-diphosphocytidyl-
RT   2C-methyl-D-erythritol 2-phosphate to 2C-methyl-D-erythritol 2,4-
RT   cyclodiphosphate.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:2486-2490(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RA   Takagi M., Kuzuyama T., Kaneda K., Watanabe H., Dairi T., Seto H.;
RT   "Studies on the nonmevalonate pathway: formation of 2-C-methyl-D-
RT   erythritol 2,4-cyclodiphosphate from 2-phospho-4-(cytidine 5'-
RT   diphospho)-2-C-methyl-D-erythritol.";
RL   Tetrahedron Lett. 41:3395-3398(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=B / BL21;
RX   PubMed=10493123;
RX   DOI=10.1002/(SICI)1522-2683(19990801)20:11<2181::AID-ELPS2181>3.0.CO;2-Q;
RA   Fountoulakis M., Takacs M.-F., Berndt P., Langen H., Takacs B.;
RT   "Enrichment of low abundance proteins of Escherichia coli by
RT   hydroxyapatite chromatography.";
RL   Electrophoresis 20:2181-2195(1999).
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=12270818; DOI=10.1128/JB.184.20.5609-5618.2002;
RA   Campbell T.L., Brown E.D.;
RT   "Characterization of the depletion of 2-C-methyl-D-erythritol-2,4-
RT   cyclodiphosphate synthase in Escherichia coli and Bacillus subtilis.";
RL   J. Bacteriol. 184:5609-5618(2002).
RN   [8]
RP   FUNCTION AS AN MECDP-SYNTHASE, CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   SUBSTRATE SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22839733; DOI=10.1021/cb300243w;
RA   Bitok J.K., Meyers C.F.;
RT   "2C-Methyl-d-erythritol 4-phosphate enhances and sustains
RT   cyclodiphosphate synthase IspF activity.";
RL   ACS Chem. Biol. 7:1702-1710(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND DIVALENT CATIONS, COFACTOR, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=11786530; DOI=10.1074/jbc.C100739200;
RA   Richard S.B., Ferrer J.-L., Bowman M.E., Lillo A.M., Tetzlaff C.N.,
RA   Cane D.E., Noel J.P.;
RT   "Structure and mechanism of 2-C-methyl-D-erythritol 2,4-
RT   cyclodiphosphate synthase. An enzyme in the mevalonate-independent
RT   isoprenoid biosynthetic pathway.";
RL   J. Biol. Chem. 277:8667-8672(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND DIVALENT CATIONS, MUTAGENESIS OF ASP-8; HIS-42 AND ASP-56,
RP   COFACTOR, AND SUBUNIT.
RX   PubMed=11829504; DOI=10.1006/jmbi.2001.5341;
RA   Steinbacher S., Kaiser J., Wungsintaweekul J., Hecht S.,
RA   Eisenreich W., Gerhardt S., Bacher A., Rohdich F.;
RT   "Structure of 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase
RT   involved in mevalonate-independent biosynthesis of isoprenoids.";
RL   J. Mol. Biol. 316:79-88(2002).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND DIVALENT CATIONS, COFACTOR, AND SUBUNIT.
RX   PubMed=11997478; DOI=10.1073/pnas.102679799;
RA   Kemp L.E., Bond C.S., Hunter W.N.;
RT   "Structure of 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase: an
RT   essential enzyme for isoprenoid biosynthesis and target for
RT   antimicrobial drug development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:6591-6596(2002).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND DIVALENT CATIONS, COFACTOR, AND SUBUNIT.
RX   PubMed=15608374; DOI=10.1107/S0907444904025971;
RA   Kemp L.E., Alphey M.S., Bond C.S., Ferguson M.A., Hecht S., Bacher A.,
RA   Eisenreich W., Rohdich F., Hunter W.N.;
RT   "The identification of isoprenoids that bind in the intersubunit
RT   cavity of Escherichia coli 2C-methyl-D-erythritol-2,4-cyclodiphosphate
RT   synthase by complementary biophysical methods.";
RL   Acta Crystallogr. D 61:45-52(2005).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.11 ANGSTROMS) OF DOUBLE MUTANT
RP   MET-142/LEU-144 IN COMPLEX WITH SUBSTRATE ANALOGS AND DIVALENT
RP   CATIONS, MUTAGENESIS OF ARG-142 AND GLU-144, AND COFACTOR.
RX   PubMed=16511114; DOI=10.1107/S1744309105018762;
RA   Sgraja T., Kemp L.E., Ramsden N., Hunter W.N.;
RT   "A double mutation of Escherichia coli2C-methyl-D-erythritol-2,4-
RT   cyclodiphosphate synthase disrupts six hydrogen bonds with, yet fails
RT   to prevent binding of, an isoprenoid diphosphate.";
RL   Acta Crystallogr. F 61:625-629(2005).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND ZINC IONS, COFACTOR, AND SUBUNIT.
RX   PubMed=16392111; DOI=10.1002/anie.200503003;
RA   Crane C.M., Kaiser J., Ramsden N.L., Lauw S., Rohdich F.,
RA   Eisenreich W., Hunter W.N., Bacher A., Diederich F.;
RT   "Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate
RT   pathway for isoprenoid biosynthesis and a potential target for
RT   antimalarial therapy.";
RL   Angew. Chem. Int. Ed. 45:1069-1074(2006).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS AND ZINC IONS, COFACTOR, AND SUBUNIT.
RX   PubMed=19320487; DOI=10.1021/jm801475n;
RA   Ramsden N.L., Buetow L., Dawson A., Kemp L.A., Ulaganathan V.,
RA   Brenk R., Klebe G., Hunter W.N.;
RT   "A structure-based approach to ligand discovery for 2C-methyl-D-
RT   erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial
RT   therapy.";
RL   J. Med. Chem. 52:2531-2542(2009).
CC   -!- FUNCTION: Involved in the biosynthesis of isopentenyl diphosphate
CC       (IPP) and dimethylallyl diphosphate (DMAPP), two major building
CC       blocks of isoprenoid compounds. Catalyzes the conversion of 4-
CC       diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to
CC       2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a
CC       corresponding release of cytidine 5-monophosphate (CMP). Also
CC       converts 4-diphosphocytidyl-2-C-methyl-D-erythritol into 2-C-
CC       methyl-D-erythritol 3,4-cyclophosphate and CMP.
CC       {ECO:0000269|PubMed:10694574, ECO:0000269|PubMed:22839733}.
CC   -!- CATALYTIC ACTIVITY: 2-phospho-4-(cytidine 5'-diphospho)-2-C-
CC       methyl-D-erythritol = 2-C-methyl-D-erythritol 2,4-cyclodiphosphate
CC       + CMP. {ECO:0000269|PubMed:10694574, ECO:0000269|PubMed:22839733}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000269|PubMed:10694574,
CC         ECO:0000269|PubMed:11786530, ECO:0000269|PubMed:11829504,
CC         ECO:0000269|PubMed:11997478, ECO:0000269|PubMed:15608374,
CC         ECO:0000269|PubMed:16392111, ECO:0000269|PubMed:16511114,
CC         ECO:0000269|PubMed:19320487};
CC       Note=Binds 1 divalent metal cation per subunit.
CC       {ECO:0000269|PubMed:10694574, ECO:0000269|PubMed:11786530,
CC       ECO:0000269|PubMed:11829504, ECO:0000269|PubMed:11997478,
CC       ECO:0000269|PubMed:15608374, ECO:0000269|PubMed:16392111,
CC       ECO:0000269|PubMed:16511114, ECO:0000269|PubMed:19320487};
CC   -!- ENZYME REGULATION: Activated by 2C-methyl-D-erythritol 4-phosphate
CC       (MEP). {ECO:0000269|PubMed:22839733}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=339 uM for CDP-ME2P (at pH 7.4)
CC         {ECO:0000269|PubMed:22839733};
CC         Note=kcat is 61 min(-1) for CDP-ME2P (at pH 7.4).;
CC   -!- PATHWAY: Isoprenoid biosynthesis; isopentenyl diphosphate
CC       biosynthesis via DXP pathway; isopentenyl diphosphate from 1-
CC       deoxy-D-xylulose 5-phosphate: step 4/6.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:11786530,
CC       ECO:0000269|PubMed:11829504, ECO:0000269|PubMed:11997478,
CC       ECO:0000269|PubMed:15608374, ECO:0000269|PubMed:16392111,
CC       ECO:0000269|PubMed:16511114, ECO:0000269|PubMed:19320487}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene reveal a filamentous
CC       phenotype. {ECO:0000269|PubMed:12270818}.
CC   -!- SIMILARITY: Belongs to the IspF family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L07942; AAA79837.1; -; Genomic_DNA.
DR   EMBL; AF230738; AAF44656.1; -; Genomic_DNA.
DR   EMBL; AB038256; BAA95145.1; -; Genomic_DNA.
DR   EMBL; U29579; AAA69256.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75788.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76823.1; -; Genomic_DNA.
DR   PIR; I55083; I55083.
DR   RefSeq; NP_417226.1; NC_000913.3.
DR   RefSeq; WP_001219242.1; NZ_LN832404.1.
DR   PDB; 1GX1; X-ray; 1.80 A; A/B/C=1-159.
DR   PDB; 1H47; X-ray; 2.00 A; A/B/C/D/E/F=1-159.
DR   PDB; 1H48; X-ray; 2.30 A; A/B/C/D/E/F=1-159.
DR   PDB; 1JY8; X-ray; 2.50 A; A=1-159.
DR   PDB; 1KNJ; X-ray; 2.80 A; A=1-159.
DR   PDB; 1KNK; X-ray; 2.80 A; A=1-159.
DR   PDB; 1U3L; X-ray; 2.50 A; A=1-159.
DR   PDB; 1U3P; X-ray; 2.85 A; A=1-159.
DR   PDB; 1U40; X-ray; 2.80 A; A=1-159.
DR   PDB; 1U43; X-ray; 3.20 A; A=1-159.
DR   PDB; 1YQN; X-ray; 3.11 A; A=1-159.
DR   PDB; 2AMT; X-ray; 2.30 A; A/B/C/D/E/F=1-159.
DR   PDB; 2GZL; X-ray; 2.50 A; A=1-157.
DR   PDB; 3ELC; X-ray; 2.50 A; A/B/C=1-159.
DR   PDB; 3EOR; X-ray; 2.90 A; A=1-159.
DR   PDB; 3ERN; X-ray; 2.10 A; A/B/C/D/E/F=1-159.
DR   PDB; 3ESJ; X-ray; 2.70 A; A=1-159.
DR   PDB; 3FBA; X-ray; 3.10 A; A=1-159.
DR   PDBsum; 1GX1; -.
DR   PDBsum; 1H47; -.
DR   PDBsum; 1H48; -.
DR   PDBsum; 1JY8; -.
DR   PDBsum; 1KNJ; -.
DR   PDBsum; 1KNK; -.
DR   PDBsum; 1U3L; -.
DR   PDBsum; 1U3P; -.
DR   PDBsum; 1U40; -.
DR   PDBsum; 1U43; -.
DR   PDBsum; 1YQN; -.
DR   PDBsum; 2AMT; -.
DR   PDBsum; 2GZL; -.
DR   PDBsum; 3ELC; -.
DR   PDBsum; 3EOR; -.
DR   PDBsum; 3ERN; -.
DR   PDBsum; 3ESJ; -.
DR   PDBsum; 3FBA; -.
DR   ProteinModelPortal; P62617; -.
DR   SMR; P62617; -.
DR   BioGrid; 4262279; 275.
DR   DIP; DIP-48029N; -.
DR   IntAct; P62617; 7.
DR   STRING; 511145.b2746; -.
DR   BindingDB; P62617; -.
DR   ChEMBL; CHEMBL3217375; -.
DR   DrugBank; DB02552; Geranyl Diphosphate.
DR   PaxDb; P62617; -.
DR   PRIDE; P62617; -.
DR   EnsemblBacteria; AAC75788; AAC75788; b2746.
DR   EnsemblBacteria; BAE76823; BAE76823; BAE76823.
DR   GeneID; 945057; -.
DR   KEGG; ecj:JW2716; -.
DR   KEGG; eco:b2746; -.
DR   PATRIC; 32120898; VBIEscCol129921_2841.
DR   EchoBASE; EB1763; -.
DR   EcoGene; EG11816; ispF.
DR   eggNOG; ENOG4108UH8; Bacteria.
DR   eggNOG; COG0245; LUCA.
DR   HOGENOM; HOG000239175; -.
DR   InParanoid; P62617; -.
DR   KO; K01770; -.
DR   OMA; IRIGNGY; -.
DR   PhylomeDB; P62617; -.
DR   BioCyc; EcoCyc:EG11816-MONOMER; -.
DR   BioCyc; MetaCyc:EG11816-MONOMER; -.
DR   BRENDA; 4.6.1.12; 2026.
DR   UniPathway; UPA00056; UER00095.
DR   EvolutionaryTrace; P62617; -.
DR   PRO; PR:P62617; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0008685; F:2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0030145; F:manganese ion binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IDA:EcoCyc.
DR   GO; GO:0008270; F:zinc ion binding; IDA:EcoCyc.
DR   GO; GO:0019288; P:isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway; IEA:UniProtKB-UniPathway.
DR   GO; GO:0016114; P:terpenoid biosynthetic process; IEA:InterPro.
DR   GO; GO:0006744; P:ubiquinone biosynthetic process; IDA:EcoCyc.
DR   CDD; cd00554; MECDP_synthase; 1.
DR   Gene3D; 3.30.1330.50; -; 1.
DR   HAMAP; MF_00107; IspF; 1.
DR   InterPro; IPR003526; MECDP_synthase.
DR   InterPro; IPR020555; MECDP_synthase_CS.
DR   Pfam; PF02542; YgbB; 1.
DR   SUPFAM; SSF69765; SSF69765; 1.
DR   TIGRFAMs; TIGR00151; ispF; 1.
DR   PROSITE; PS01350; ISPF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Isoprene biosynthesis; Lyase; Metal-binding; Reference proteome.
FT   CHAIN         1    159       2-C-methyl-D-erythritol 2,4-
FT                                cyclodiphosphate synthase.
FT                                /FTId=PRO_0000189464.
FT   REGION        8     10       Substrate binding.
FT   REGION       34     35       Substrate binding.
FT   REGION       38     46       Substrate binding.
FT   REGION       56     58       Substrate binding.
FT   REGION       61     65       Substrate binding.
FT   REGION      100    106       Substrate binding.
FT   REGION      131    135       Substrate binding.
FT   METAL         8      8       Divalent metal cation.
FT   METAL        10     10       Divalent metal cation.
FT   METAL        42     42       Divalent metal cation.
FT   BINDING      65     65       Substrate; via carbonyl oxygen.
FT   BINDING     139    139       Substrate; via carbonyl oxygen.
FT   BINDING     142    142       Substrate.
FT   SITE         34     34       Transition state stabilizer.
FT   SITE        133    133       Transition state stabilizer.
FT   MUTAGEN       8      8       D->S: Loss of activity.
FT                                {ECO:0000269|PubMed:11829504}.
FT   MUTAGEN      42     42       H->S: Loss of activity.
FT                                {ECO:0000269|PubMed:11829504}.
FT   MUTAGEN      56     56       D->S: 35% decrease of activity.
FT                                {ECO:0000269|PubMed:11829504}.
FT   MUTAGEN     142    142       R->M: Little effect on the overall
FT                                structure; when associated with L-144.
FT                                {ECO:0000269|PubMed:16511114}.
FT   MUTAGEN     144    144       E->L: Little effect on the overall
FT                                structure; when associated with M-142.
FT                                {ECO:0000269|PubMed:16511114}.
FT   STRAND        1     16       {ECO:0000244|PDB:1GX1}.
FT   STRAND       18     20       {ECO:0000244|PDB:1GX1}.
FT   STRAND       23     25       {ECO:0000244|PDB:1GX1}.
FT   STRAND       28     31       {ECO:0000244|PDB:1GX1}.
FT   STRAND       33     35       {ECO:0000244|PDB:1GX1}.
FT   HELIX        39     51       {ECO:0000244|PDB:1GX1}.
FT   HELIX        57     60       {ECO:0000244|PDB:1GX1}.
FT   STRAND       63     65       {ECO:0000244|PDB:1U43}.
FT   HELIX        66     68       {ECO:0000244|PDB:1GX1}.
FT   STRAND       69     71       {ECO:0000244|PDB:2GZL}.
FT   HELIX        73     86       {ECO:0000244|PDB:1GX1}.
FT   STRAND       90     99       {ECO:0000244|PDB:1GX1}.
FT   STRAND      101    103       {ECO:0000244|PDB:1GX1}.
FT   HELIX       106    108       {ECO:0000244|PDB:1GX1}.
FT   HELIX       109    119       {ECO:0000244|PDB:1GX1}.
FT   HELIX       124    126       {ECO:0000244|PDB:1GX1}.
FT   STRAND      127    132       {ECO:0000244|PDB:1GX1}.
FT   HELIX       138    141       {ECO:0000244|PDB:1GX1}.
FT   STRAND      144    155       {ECO:0000244|PDB:1GX1}.
SQ   SEQUENCE   159 AA;  16898 MW;  9FC5563623A62939 CRC64;
     MRIGHGFDVH AFGGEGPIII GGVRIPYEKG LLAHSDGDVA LHALTDALLG AAALGDIGKL
     FPDTDPAFKG ADSRELLREA WRRIQAKGYT LGNVDVTIIA QAPKMLPHIP QMRVFIAEDL
     GCHMDDVNVK ATTTEKLGFT GRGEGIACEA VALLIKATK
//
